Amylin news

All news on Amylin (also known as Islet amyloid polypeptide and IAPP): plants, production capacities, investments and involved companies.

5 March 2026

Roche Reports Positive Phase II Results for Petrelintide in Obesity Treatment

Petrelintide shows significant weight loss and good tolerability in Phase II trial, supporting further development for chronic weight management.
5 March 2026

Genentech Reports Positive Phase II Results for Petrelintide in Obesity Treatment

Petrelintide shows significant weight loss and good tolerability in Phase II trial, supporting further development for chronic weight management.
16 September 2025

Novo Nordisk Advances Cagrilintide to Phase 3 Clinical Program After Positive Results

Cagrilintide shows significant weight loss and tolerability in trials, prompting further study in the RENEW phase 3 program for obesity treatment.

Who will be producing Amylin in the future?

Find out with chemXplore Alpha

Learn more